Evidence map›Paper›PMID 38735907›Full record

ArticleHead and neck pathology2024

A Novel Gene Fusion YLPM1::PRKD1 Identified in a Cribriform Subtype of Polymorphous Adenocarcinoma.

Monica Miyakawa-Liu, Michael G Ozawa, Michelle Chen, Mobeen Rahman

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Head and neck pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Monica Miyakawa-LiuDepartment of Pathology, Stanford University School of Medicine, Stanford, USA. mmiyakaw@stanford.edu.
Michael G OzawaDepartment of Pathology, Stanford University School of Medicine, Stanford, USA.
Michelle ChenDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, USA.
Mobeen RahmanDepartment of Pathology, Stanford University School of Medicine, Stanford, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cribriform adenocarcinoma of the salivary gland (CASG) is an entity that is currently classified under polymorphous adenocarcinoma (PAC), cribriform subtype per the 2022 WHO classification of head and neck tumours. There is debate about whether CASG should be considered a separate diagnostic entity, as CASG differs from conventional PAC in anatomic site, clinical behaviors, and molecular patterns. Herein we describe a challenging and unique case which shares histologic and behavioral features between CASG and conventional PAC with a YLPM1::PRKD1 rearrangement not previously reported in the literature.

Indexed as

AdenocarcinomaOncogene Proteins, FusionSalivary Gland NeoplasmsFemaleGene FusionHumansMaleMiddle AgedProtein Kinase CRepressor ProteinsRNA-Binding ProteinsOncogene Proteins, FusionProtein Kinase Cprotein kinase DRepressor ProteinsRNA-Binding ProteinsYLPM1 protein, humanGene fusionHead and neck pathologyOral pathologyPalateSalivary gland neoplasm

Identifiers

PMID38735907
PMCPMC11089030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.